Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine.

MLA

Tassorelli, C., et al. “Safety Findings from CENTURION, a Phase 3 Consistency Study of Lasmiditan for the Acute Treatment of Migraine.” Journal of Headache & Pain, vol. 22, no. 1, Nov. 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s10194-021-01343-2.

APA

Tassorelli, C., Bragg, S., Krege, J., Doty, E., Ardayfio, P., Ruff, D., Dowsett, S., & Schwedt, T. (2021). Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine. Journal of Headache & Pain, 22(1), 1–8. https://doi.org/10.1186/s10194-021-01343-2

Chicago

Tassorelli, C, S Bragg, Jh Krege, Eg Doty, Pa Ardayfio, D Ruff, Sa Dowsett, and T Schwedt. 2021. “Safety Findings from CENTURION, a Phase 3 Consistency Study of Lasmiditan for the Acute Treatment of Migraine.” Journal of Headache & Pain 22 (1): 1–8. doi:10.1186/s10194-021-01343-2.